Mabpharm Limited
HKEX:2181.HK
0.295 (HKD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 173.345 | 33.568 | 81.556 | 484.846 | 588.72 | 198.195 | 76.443 |
| Short Term Investments
| 0 | 15.044 | 0 | 0 | 179.16 | 0 | 0 |
| Cash and Short Term Investments
| 173.345 | 48.612 | 81.556 | 484.846 | 767.88 | 198.195 | 76.443 |
| Net Receivables
| 19.423 | 9.532 | 0.793 | 0 | 0 | 0 | 0.484 |
| Inventory
| 102.037 | 100.797 | 53.211 | 33.427 | 22.224 | 27.551 | 36.319 |
| Other Current Assets
| 47.401 | 42.179 | 112.21 | 50.853 | 165.035 | 35.007 | 41.689 |
| Total Current Assets
| 342.206 | 201.12 | 247.77 | 569.126 | 955.139 | 260.753 | 154.935 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 686.536 | 713.589 | 642.9 | 559.687 | 389.89 | 154.072 | 117.758 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 38.11 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 38.11 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 6.231 | 2.812 | 9.232 | 34.224 | 51.448 | 20.287 | 16.449 |
| Total Non-Current Assets
| 692.767 | 716.401 | 652.132 | 593.911 | 441.338 | 212.469 | 134.207 |
| Total Assets
| 1,034.973 | 917.521 | 899.902 | 1,163.037 | 1,396.477 | 473.222 | 289.142 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 10.026 | 16.586 | 12.86 | 4.52 | 4.401 | 1.797 | 1.092 |
| Short Term Debt
| 125.258 | 13.291 | 9.283 | 8.532 | 70.5 | 40 | 10 |
| Tax Payables
| 0.658 | 0.935 | 1.203 | 0.594 | 0.514 | 1.755 | 0.718 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 180.249 | 157.589 | 211.658 | 188.981 | 194.919 | 112.898 | 59.043 |
| Total Current Liabilities
| 316.191 | 188.401 | 235.004 | 202.627 | 270.334 | 156.45 | 70.853 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 157.315 | 158.046 | 36.407 | 31.816 | 35.123 | 65 | 65 |
| Deferred Revenue Non-Current
| 0 | 122.433 | 26.51 | 47.109 | 37.309 | 2.2 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | -26.51 | -47.109 | -37.309 | -2.2 | 0 |
| Other Non-Current Liabilities
| 356.41 | 170.13 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 513.725 | 328.176 | 62.917 | 78.925 | 72.432 | 67.2 | 65 |
| Total Liabilities
| 829.916 | 516.577 | 297.921 | 281.552 | 342.766 | 223.65 | 135.853 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 1.068 | 13.474 | 133.594 | 0 |
| Common Stock
| 2.804 | 2.804 | 2.804 | 2.804 | 2.804 | 0.051 | 0 |
| Retained Earnings
| -1,232.674 | -1,023.318 | -812.499 | -520.755 | -336.123 | -133.594 | -32.705 |
| Accumulated Other Comprehensive Income/Loss
| 34.423 | 20.954 | 11.172 | -1.068 | -13.474 | -26.882 | -14.651 |
| Other Total Stockholders Equity
| 1,400.504 | 1,400.504 | 1,400.504 | 1,400.504 | 1,400.504 | 410.433 | 147.169 |
| Total Shareholders Equity
| 205.057 | 400.944 | 601.981 | 881.485 | 1,053.711 | 249.572 | 99.813 |
| Total Equity
| 205.057 | 400.944 | 601.981 | 881.485 | 1,053.711 | 249.572 | 153.289 |
| Total Liabilities & Shareholders Equity
| 1,034.973 | 917.521 | 899.902 | 1,163.037 | 1,396.477 | 473.222 | 289.142 |